DOI: https://doi.org/10.22141/2224-1485.5.55.2017.115337
Morning blood pressure surge in patients with mild to moderate arterial hypertension and a method of correction with metoprolol retard
Abstract
Keywords
Full Text:
PDF (Русский)References
Сиренко Ю.Н. Медикаментозная первичная и вторичная профилактика ишемической болезни сердца у больных артериальной гипертензией // Ліки України. — 2005. — № 1. — С. 9-13.
Сиренко Ю.Н., Рековец О.Л., Дзяк Г.В., Багрий А.Э., Поливода С.Н., Визир В.А., Андриевская С.А., Ханюков А.А., Черепок А.А., Приколота О.А., Березин А.Е., Говорова О.В. Антигипертензивная эффективность метопролола ретарда у больных с мягкой и умеренной артериальной гипертензией (результаты многоцентрового исследования ProlongER) // Український кардіологічний журнал. — 2005. — № 2. — С. 35-41.
1999 WHO — ISH guidelines for the management of hypertension // J. Hypertension. — 1999. — Vol. 11. — P. 905-916.
Agrawal Y.K., Patel R.N. Chiral chromatographic separation of beta-blockers // J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. — 2005. — Vol. 1. — P. 23-31.
Al-Saidan S.M., Krishnaiah Y.S., Satyanarayana V. еt al. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug // Eur. J. Pharm. Biopharm. — 2004. — Vol. 3. — P. 697-703.
Atar I., Korkmaz M.E., Demirkan S. еt al. Beta blocker effects on plasma homocysteine levels in patients with hypertension // Atherosclerosis. — 2005. — Vol. 2. — P. 399-402.
Coragem Briguenti A.C., Bonato P.S. Quantitative analysis of beta-blockers in pharmaceutical preparations by capillary electrophoresis // Drug Dev. Ind. Pharm. — 2005. — Vol. 2. — P. 209-214.
Elliott H.L. 24-hour control of cardiovascular disease. — London: Science Press, 1995. — P. 48.
Formes K.J., Wray D.W., O-Yurvati A.H., Weiss M.S., Shi X. Sympathetic cardiac influence and arterial blood pressure instability //Auton. Neurosci. — 2005. — Vol. 1–2. — P. 116-124.
Genova G., Rabbia F., Milan A. et al. Autonomic nervous pattern influence before treatment, on the response to antihypertensive therapy in never treated mild hypertensive patients // J. Hypertens. — 2001. — Vol. 19. — P. 128S.
Hansson L., Hedner T. Hypertension Manual 2000. — Layout Bohlin Production AB, 2000. — 128 p.
Hypertension Primer. The essentials of high blood pressure. From the council on high blood pressure research American Heart Association, 1999. — P. 471.
Ishikawa J., Kario K., Hoshide S. еt al. Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) Study // Am. J. Hypertens. — 2005. — Vol. 7. — P. 958-965.
Johannesson M., Dahlof B., Lindholm L.H. et al. The cost-effectiveness of treating hypertension in elderly people — an analysis of the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) // J. Intern. Med. — 1993. — Vol. 234. — P. 317-323.
Jonsson B., Hansson L., Stalhammar N.O. Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost-effectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension // J. Intern. Med. — 2003. — Vol. 253. — P. 472-480.
Kario K. Early morning risk management in hypertension. — London: Science Рress, 2004. — P. 3-11.
Kasim N.A., Whitehouse M., Ramachandran C. еt al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification // Mol. Pharm. — 2004. — Vol. 1. — P. 85-96.
Koch H.J., Raschka C. Relation between pharmacodynamic and anthropometric parameters during ergometry at rest and after repeated intake of metoprolol in healthy volunteers: results of a pilot study // Acta. Physiol. Hung. — 2004. — Vol. 1. — P. 67-72.
Marfella R., Siniscalchi M., Nappo F. еt al. Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients // Am. J. Hypertens. — 2005. — Vol. 3. — P. 308-318.
Melenovsky V., Simek J., Sperl M. еt al. Relation between actual heart rate and autonomic effects of beta blockade in healthy men // Am. J. Cardiol. — 2005. — Vol. 8. — P. 999-1002.
Rahman N., Rahman H., Azmi S.N. Validated kinetic spectrophotometric method for the determination of metoprolol tartrate in pharmaceutical formulations // Chem. Pharm. Bull. — 2005. — Vol. 8. — P. 942-948.
Sakima A., Takishita S. Therapeutic strategy for mor-ning blood pressure elevation in elderly hypertensives // Nippon. Rinsho. — 2005. — Vol. 6. — P. 1086-1090.
Taguchi M., Nozawa T., Mizumaki K. еt al. Nonlinear mixed effects model analysis of the pharmacokinetics of metoprolol in routinely treated Japanese patients // Biol. Pharm. Bull. — 2004. — Vol. 10. — P. 1642-1648.
Van den Born B.J., Brewster L.M., Koopmans R.P.,
van Montfrans G.A. Atenolol or metoprolol as beta-blocker in the treatment of hypertension // Ned. Tijdschr. Geneeskd. — 2005. — Vol. 32. — P. 1808-1809.
Van der Steen M.S., Lenders J.W., Thien T. Side effects of ambulatory blood pressure monitoring // Blood Press. Monit. — 2005. — Vol. 3. — P. 151-155.
Van der Woude H.J., Zaagsma J., Postma D.S. еt al. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers // Chest. — 2005. — Vol. 3. — P. 818-824.
Verdecchia P., Angeli F. How can we use the results of ambulatory blood pressure monitoring in clinical practice? // Hypertension. — 2005. — Vol. 1. — P. 25-26.
White W. Blood pressure monitoring in cardiovascular medicine and therapeutics. — New Jersey: Humana Press, 2001. — P. 308.
Wuerzner G., Chiolero A., Maillard M. еt al. Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men // Kidney Int. — 2005. — Vol. 2. — P. 688-694.
Copyright (c) 2017 HYPERTENSION

This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2018
